Dr. Uttam comes from research background and has worked on several multidisciplinary projects during his time in academics. Prior to joining ABVC, He served as a post-doctoral fellow at National Taiwan Normal after receiving his Ph.D. from the National Tsing Hua University, Department of Chemistry.

Dr. Uttam serves as the R&D Manager of Rgene Corporation, a Taiwanese company committed to developing new plant-based drugs and combination cancer therapies to provide better medical assistance for improving the patient’s quality of life. He also serves as Chief Operating & Scientific Officer BioKey, Inc., a GMP-certified facility that provides its clients with integrated pharmaceutical services, including early-phase product development, formulation development, analytical development & drug product manufacturing.